INTRODUCTION
Chronic opioid use, to which physician opioid-prescribing behavior may contribute, is associated with overdose and death. 1, 2 Prior research has found that higher opioidprescribing intensity among physicians in the same emergency department is associated with greater chronic opioid use. 3 Whether a similar relationship holds for surgeons within the same practice for common outpatient surgical procedures, such as arthroscopic meniscectomies, is unknown.
METHODS
I performed analyses using 2011-2014 claims data for a random 20% sample of Medicare beneficiaries. I identified arthroscopic meniscectomies performed on beneficiaries aged 65 and over who were continuously enrolled in Medicare Parts A, B, and D for at least 6 months before the procedure and at least 12 months after who did not have a hospice claim or cancer diagnosis during this time interval. 3 Consistent with prior literature on surgical patients, I excluded patients with 7 or more days of opioids supplied in the 6 months prior to the procedure. 4 Using Part D data, I attributed the first oral opioid prescription filled by patients within 14 days of the procedure to the surgeon. I calculated the median dose in morphine equivalents by surgeon after meniscectomies. I compared patients treated by high-dose and low-dose prescribing surgeons within the same practice. This strategy assumes patients do not select between surgeons in the same practice based on the surgeon's opioid-prescribing intensity, and therefore, patients treated within the same practice have similar propensities of developing chronic opioid use. The main explanatory variable was a binary indicator for whether the surgeon was a high-dose prescriber (in the top quartile of median dose in their practice) or low-dose prescriber (in the bottom quartile) [or highest and lowest median dose for practices with fewer than four surgeons], excluding practices where the difference between the upper and lower quartile was less than 50 morphine equivalents. The outcome was chronic opioid use, a binary indicator defined as 180 days or more of opioids supplied in the 365 days subsequent to the procedure, excluding the first 30 days.
3 I estimated linear probability models of the outcome as a function of dose intensity, controlling for patient age, sex, race and ethnicity, dual eligibility for Medicaid, current disability status, year, and diagnosis of the 11 chronic conditions listed in Table 1. 3 I clustered standard errors at the practice level. I obtained study approval from the National Bureau of Economic Research.
RESULTS
The sample included 1360 patients treated by a low-dose prescriber and 1331 treated by a high-dose prescriber ( Table 1 ). The rate of chronic opioid use after a meniscectomy was 0.30%. The average median dose was 70 morphine equivalents for low-dose prescribers and 304 morphine equivalents for high-dose prescribers (p value < 0.001 for the difference). There were no statistically significant differences in characteristics between patients treated by high-dose versus low-dose prescribers. After adjustment for patient characteristics and year, the difference in rate of chronic opioid use between those treated by high-dose versus low-dose prescribers was 0.46 percentage points (95% CI 0.04 to 0.87) ( Table 2 ). Results were largely unchanged when excluding those with any exposure to opioids (difference of 0.44 percentage points [95% CI − 0.03 to 0.91]). Results were unchanged when using logistic regression.
DISCUSSION
There is an over four-fold difference in median dose of first opioid prescription filled within the same practice in many orthopedic practices. Patients treated by high-dose prescribers within these practices had higher rates of developing chronic opioid use. Results are limited to the Medicare population with Part D undergoing meniscectomy and may not generalize to other populations. Differences within practices in surgery quality rather than differences in opioid prescribing may drive differences in the rate of developing chronic opioid use.
